Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
06/2006
06/07/2006EP1663254A2 Anti-inflamatory phosphonate conjugates
06/07/2006EP1663232A1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
06/07/2006EP1663223A2 Thalidomide analogs as tnf-alpha modulators
06/07/2006EP1663221A1 Ophthalmic compositions for treating ocular hypertension
06/07/2006EP1373188B1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics
06/07/2006CN1781910A Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
06/07/2006CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators
06/07/2006CN1258529C Process for preparing diaryl-4-amino-piperidinyl compounds
06/06/2006US7057049 Mitogen-activated protein kinase inhibitors
06/06/2006US7056925 Urea kinase inhibitors
06/06/2006US7056915 Compounds useful as reversible inhibitors of cysteine proteases
06/06/2006US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc.
06/06/2006US7056709 Isolation and expression of a gene for a nitrilase from Acidovorax faclilis 72W
06/06/2006US7056600 Layer configuration comprising an electron-blocking element
06/06/2006CA2213526C Stabilizer mixtures
06/06/2006CA2136903C Acetic acid derivatives
06/01/2006WO2006058182A2 Lighting elements, devices and methods
06/01/2006WO2006058080A1 Treatment of inflammatory bowel disease
06/01/2006WO2006057904A1 Stereoselective preparation of 4-aryl piperidine amides by asymmetric hydrogenation of a prochiral enamide and intermediates of this process
06/01/2006WO2006057845A1 Aromatic ether derivatives useful as thrombin inhibitors
06/01/2006WO2006056696A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
06/01/2006WO2006056129A1 Compositions of huperzia serrata alkaloids comprising huperzine a and huperzine b and preparation thereof
06/01/2006WO2006036949A3 Preparation of n-aryl pyridones
06/01/2006WO2005118537A3 Arylpiperazine derivatives as adrenergic receptor antagonists
06/01/2006US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis
06/01/2006US20060116399 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
06/01/2006US20060116398 E.g., biphenyl-2-ylcarbamic acid 1-{9-[2-(4-hydroxy-2-oxo-2,3-dihydrobenzothiazol-7-yl)ethylamino]nonyl}piperidin-4-yl ester;respiratory system disorders; bronchodilators; chronic obstructive pulmonary disease or asthma; affinity for dopamine D2 receptors; used with phosphodiesterase-4 inhibitor
06/01/2006CA2589438A1 Treatment of inflammatory bowel disease
06/01/2006CA2587888A1 Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors
06/01/2006CA2586972A1 Cycloalkyl piperidine tachykinin receptor antagonists
05/2006
05/31/2006EP1661885A1 Optically active alpha-aminooxyketone derivatives and process for production thereof
05/31/2006EP1661881A2 Compound capable of binding s1p receptor and pharmaceutical use thereof
05/31/2006EP1660472A1 Aryl piperidine amides
05/31/2006EP1660471A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors
05/31/2006EP1660443A2 Cyclic amine bace-1 inhibitors having a benzamide substituent
05/31/2006EP1420644B1 Substituted propargylamines
05/31/2006EP1401821A4 Novel phenylalkyl diamine and amide analogs
05/31/2006EP1350108B1 Method for identifying ligands for a biological substrate
05/31/2006CN1780818A Derivados c¿¼clicos fenil-substitu¿¼dos
05/31/2006CN1780815A Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
05/31/2006CN1780810A Asymmetric-synthesis catalyst based on chiral broensted acid and method of asymmetric synthesis with the catalyst
05/31/2006CN1780622A 4-(2-phenylsulfanyl-phenyl)-piperidine derivates as serotonin reuptake inhibitors
05/31/2006CN1780621A Sulfonamide derivatives as gamma secretase inhibitors.
05/31/2006CN1257901C Tetrahydroquinoline ketopiperidine compounds and their preparation and use
05/31/2006CN1257886C Dehydroamino acids compounds
05/30/2006USRE39113 Neuropathic pain; in humans, animals
05/30/2006US7053234 Antibacterial agents
05/30/2006US7053212 Subtype selectivity; cyclohexanecarboxylic acid (4-hydroxy-benzyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide for example; treating estrogen-related disorders such as sexual disorders, bone disorders; reduction of tamoxifen uterotropic effect
05/30/2006US7053085 EP4 receptor agonist, compositions and methods thereof
05/30/2006US7053078 Serine protease inhibitors
05/30/2006US7053057 Caspase inhibitors and uses thereof
05/30/2006US7052863 Chromogenic substrate for use in monitoring and detecting preferential enzymatic activities
05/30/2006CA2345582C Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
05/30/2006CA2202577C Process for producing piperidinecarbinols
05/30/2006CA2106613C Benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them
05/26/2006WO2006055321A2 Process of making fentanyl intermediates
05/26/2006WO2006055187A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar
05/26/2006WO2006053429A1 Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
05/26/2006WO2006010079A3 Process for preparing naratriptan hydrochloride
05/26/2006WO2006002361A3 2-methylpropanamides and their use as pharmaceuticals
05/26/2006WO2005108358A3 Pyrrolidine derivatives useful as bace inhibitors
05/26/2006CA2585172A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar
05/26/2006CA2581863A1 Process of making fentanyl intermediates
05/25/2006US20060111553 Novel thrombin inhibitors, the preparation and use thereof
05/25/2006US20060111406 Amide linker peroxisome proliferator activated receptor modulators
05/25/2006US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
05/25/2006US20060111399 Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation
05/25/2006US20060111352 Acetylenic compounds useful in treating inflammatory disorders
05/25/2006US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases
05/24/2006EP1659111A2 Piperidine derivatives useful as ccr5 antagonists
05/24/2006EP1658847A2 Indane derivatives as dermal anesthetic agents
05/24/2006EP1658077A2 Dual function compounds and uses thereof
05/24/2006EP1478613B1 Substituted 10-aryl-11h-benzo¬b|fluorenes for selective effects on estrogen receptors
05/24/2006CN1777601A Nk-2 antagonist basic linear compounds and formulations containing them
05/24/2006CN1777586A Stable amorphous amlodipine camsylate, process for preparing same and composition for oral administration thereof
05/24/2006CN1777585A 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
05/24/2006CN1777584A (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht 1f agonists
05/24/2006CN1777577A Antibacterial agents
05/24/2006CN1775756A Process for preparing N-amino piperidine hydrochloride
05/24/2006CN1775755A Method for preparing raw material of pleuromutilin for use in tiamulin synthesizing process
05/24/2006CN1775752A Optical pure diamide compound and its use
05/23/2006US7049441 Process for preparation of benzylpiperidine compounds
05/23/2006US7049440 Chemical intermediate for tricyclic compound
05/23/2006US7049330 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
05/23/2006US7049327 For therapy of pain
05/23/2006US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots
05/23/2006US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis
05/23/2006US7049317 CCR-3 receptor antagonists
05/23/2006US7049308 For therapy of inflammatory or painful disorder
05/23/2006US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.
05/23/2006US7049271 Herbicides, acaricides, nematicides and insecticides
05/23/2006CA2242494C Novel n-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties
05/18/2006WO2006052630A1 Therapeutic substituted piperidone compounds
05/18/2006WO2006051399A1 Piperazine derivatives useful as adrenergic receptor antagonists
05/18/2006US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type
05/18/2006US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile
05/18/2006US20060106066 Benzyl substituted (piperidin-4-yl)aminobenzamido derivatives
05/18/2006US20060106065 Methods of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D- glucuitol compounds in combination therapy
05/18/2006US20060106063 dosage forms of pimavanserin tartrate, serotonin receptor antagonists, used for the treatment of psychological disorders
05/18/2006US20060106059 Melanocortin receptor ligands